| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Probiotics | 37 | 2022 | 222 | 6.470 |
Why?
|
| Gastrointestinal Microbiome | 29 | 2024 | 796 | 5.370 |
Why?
|
| Bifidobacterium | 9 | 2021 | 66 | 4.410 |
Why?
|
| Intestinal Mucosa | 20 | 2021 | 754 | 4.100 |
Why?
|
| Metagenome | 20 | 2020 | 142 | 3.940 |
Why?
|
| Gastrointestinal Tract | 19 | 2022 | 218 | 3.940 |
Why?
|
| Microbiota | 21 | 2021 | 426 | 3.510 |
Why?
|
| Colitis | 10 | 2021 | 156 | 3.200 |
Why?
|
| Bacteria | 24 | 2024 | 515 | 2.980 |
Why?
|
| Intestines | 20 | 2021 | 578 | 2.800 |
Why?
|
| Receptors, Histamine H2 | 6 | 2019 | 11 | 2.450 |
Why?
|
| Histamine | 8 | 2024 | 50 | 2.300 |
Why?
|
| Colon | 8 | 2021 | 353 | 1.980 |
Why?
|
| RNA, Ribosomal, 16S | 24 | 2022 | 382 | 1.780 |
Why?
|
| Inflammation | 10 | 2021 | 1435 | 1.770 |
Why?
|
| Feces | 18 | 2022 | 702 | 1.760 |
Why?
|
| Irritable Bowel Syndrome | 10 | 2020 | 213 | 1.490 |
Why?
|
| Biofilms | 6 | 2020 | 93 | 1.410 |
Why?
|
| Molecular Diagnostic Techniques | 7 | 2025 | 167 | 1.330 |
Why?
|
| Gene Expression Regulation, Bacterial | 9 | 2016 | 167 | 1.330 |
Why?
|
| DNA, Bacterial | 21 | 2017 | 482 | 1.300 |
Why?
|
| Clostridium Infections | 6 | 2022 | 242 | 1.280 |
Why?
|
| Jejunum | 3 | 2020 | 122 | 1.280 |
Why?
|
| Trinitrobenzenesulfonic Acid | 5 | 2021 | 23 | 1.200 |
Why?
|
| Polymerase Chain Reaction | 29 | 2021 | 1485 | 1.160 |
Why?
|
| Animals | 53 | 2022 | 33214 | 1.110 |
Why?
|
| Bacterial Proteins | 15 | 2021 | 914 | 1.110 |
Why?
|
| Staphylococcus epidermidis | 3 | 2013 | 40 | 1.070 |
Why?
|
| Carcinogenesis | 3 | 2021 | 344 | 1.060 |
Why?
|
| Sepsis | 7 | 2025 | 494 | 1.050 |
Why?
|
| Mice | 34 | 2022 | 17695 | 1.030 |
Why?
|
| Lactobacillus | 8 | 2016 | 42 | 1.020 |
Why?
|
| Germ-Free Life | 5 | 2022 | 61 | 1.010 |
Why?
|
| Humans | 148 | 2025 | 127519 | 1.000 |
Why?
|
| Cytokines | 11 | 2021 | 1326 | 0.980 |
Why?
|
| Metagenomics | 8 | 2019 | 108 | 0.970 |
Why?
|
| Sequence Analysis, DNA | 12 | 2017 | 1709 | 0.920 |
Why?
|
| Dysbiosis | 4 | 2018 | 138 | 0.910 |
Why?
|
| Disease | 3 | 2018 | 123 | 0.910 |
Why?
|
| Histidine | 4 | 2024 | 73 | 0.890 |
Why?
|
| Fusobacterium nucleatum | 2 | 2021 | 19 | 0.850 |
Why?
|
| Immunomodulation | 5 | 2021 | 78 | 0.850 |
Why?
|
| Bacteroides | 3 | 2021 | 37 | 0.850 |
Why?
|
| Communicable Diseases | 4 | 2017 | 153 | 0.830 |
Why?
|
| Signal Transduction | 9 | 2021 | 4489 | 0.830 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2018 | 638 | 0.820 |
Why?
|
| Serotonin | 2 | 2021 | 203 | 0.780 |
Why?
|
| Goblet Cells | 2 | 2021 | 101 | 0.780 |
Why?
|
| Extracellular Vesicles | 2 | 2021 | 54 | 0.770 |
Why?
|
| Helicobacter Infections | 14 | 2016 | 1286 | 0.760 |
Why?
|
| Genome, Bacterial | 5 | 2024 | 205 | 0.750 |
Why?
|
| Receptors, Histamine H1 | 2 | 2018 | 4 | 0.730 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2021 | 48 | 0.700 |
Why?
|
| Candida albicans | 2 | 2013 | 83 | 0.690 |
Why?
|
| Candida | 3 | 2014 | 79 | 0.690 |
Why?
|
| Colitis, Ulcerative | 5 | 2016 | 214 | 0.690 |
Why?
|
| Calcium Signaling | 2 | 2020 | 241 | 0.680 |
Why?
|
| Zika Virus Infection | 3 | 2019 | 176 | 0.680 |
Why?
|
| Propane | 5 | 2020 | 28 | 0.670 |
Why?
|
| Glyceraldehyde | 5 | 2020 | 28 | 0.670 |
Why?
|
| Vagina | 2 | 2012 | 203 | 0.670 |
Why?
|
| Dipeptides | 1 | 2021 | 64 | 0.660 |
Why?
|
| Gastroenteritis | 4 | 2012 | 307 | 0.650 |
Why?
|
| Anti-Bacterial Agents | 21 | 2020 | 2519 | 0.640 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2021 | 122 | 0.640 |
Why?
|
| Interleukins | 1 | 2021 | 119 | 0.640 |
Why?
|
| Gastrointestinal Diseases | 4 | 2014 | 337 | 0.640 |
Why?
|
| Health Status | 2 | 2020 | 382 | 0.640 |
Why?
|
| Helicobacter pylori | 14 | 2016 | 1344 | 0.630 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2019 | 7 | 0.620 |
Why?
|
| Enteritis | 1 | 2020 | 52 | 0.620 |
Why?
|
| Diarrhea | 2 | 2012 | 305 | 0.620 |
Why?
|
| Placenta | 4 | 2019 | 518 | 0.620 |
Why?
|
| Chloride Channels | 1 | 2019 | 60 | 0.610 |
Why?
|
| Phylogeny | 11 | 2024 | 687 | 0.610 |
Why?
|
| Macrophages | 3 | 2019 | 643 | 0.610 |
Why?
|
| Neutrophils | 1 | 2021 | 355 | 0.610 |
Why?
|
| Anti-Infective Agents | 3 | 2017 | 264 | 0.610 |
Why?
|
| Autophagy | 2 | 2019 | 405 | 0.600 |
Why?
|
| Animals, Newborn | 4 | 2020 | 1015 | 0.590 |
Why?
|
| Bacteriological Techniques | 3 | 2011 | 85 | 0.590 |
Why?
|
| Behavior, Animal | 2 | 2020 | 495 | 0.590 |
Why?
|
| Specimen Handling | 3 | 2016 | 145 | 0.590 |
Why?
|
| Microglia | 1 | 2020 | 129 | 0.590 |
Why?
|
| Bacterial Physiological Phenomena | 2 | 2010 | 19 | 0.580 |
Why?
|
| Amino Acids | 3 | 2018 | 615 | 0.580 |
Why?
|
| Fecal Microbiota Transplantation | 5 | 2022 | 104 | 0.580 |
Why?
|
| Biodiversity | 2 | 2016 | 73 | 0.570 |
Why?
|
| Metabolome | 2 | 2019 | 316 | 0.570 |
Why?
|
| Microbiological Techniques | 2 | 2009 | 31 | 0.570 |
Why?
|
| Antiporters | 2 | 2018 | 35 | 0.560 |
Why?
|
| Abdominal Pain | 7 | 2022 | 308 | 0.560 |
Why?
|
| Pediatrics | 4 | 2016 | 1205 | 0.560 |
Why?
|
| Phagocytosis | 1 | 2019 | 191 | 0.560 |
Why?
|
| Coinfection | 3 | 2014 | 185 | 0.560 |
Why?
|
| Dendritic Cells | 1 | 2021 | 435 | 0.550 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 107 | 0.540 |
Why?
|
| Diacylglycerol Kinase | 1 | 2017 | 17 | 0.540 |
Why?
|
| Mucin-2 | 4 | 2021 | 35 | 0.530 |
Why?
|
| Nerve Net | 1 | 2020 | 246 | 0.530 |
Why?
|
| Helicobacter hepaticus | 4 | 2014 | 4 | 0.520 |
Why?
|
| Protein Kinase C | 1 | 2017 | 111 | 0.520 |
Why?
|
| Genomics | 6 | 2019 | 1549 | 0.520 |
Why?
|
| Histidine Decarboxylase | 5 | 2024 | 12 | 0.510 |
Why?
|
| Bacteremia | 2 | 2014 | 420 | 0.510 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2021 | 172 | 0.510 |
Why?
|
| Peptide Synthases | 1 | 2016 | 3 | 0.500 |
Why?
|
| Visceral Pain | 1 | 2016 | 7 | 0.500 |
Why?
|
| Synapses | 1 | 2020 | 433 | 0.500 |
Why?
|
| Tumor Necrosis Factors | 3 | 2014 | 11 | 0.490 |
Why?
|
| Multienzyme Complexes | 1 | 2016 | 77 | 0.490 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 1000 | 0.470 |
Why?
|
| Mutagenesis | 2 | 2014 | 332 | 0.470 |
Why?
|
| Epithelial Cells | 6 | 2021 | 873 | 0.470 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 164 | 0.470 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 7 | 2021 | 348 | 0.470 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2018 | 211 | 0.460 |
Why?
|
| Rotavirus Infections | 2 | 2020 | 278 | 0.460 |
Why?
|
| Male | 44 | 2021 | 62900 | 0.460 |
Why?
|
| Infant, Premature | 5 | 2018 | 829 | 0.450 |
Why?
|
| Biological Therapy | 1 | 2015 | 25 | 0.450 |
Why?
|
| Enterocytes | 2 | 2012 | 65 | 0.450 |
Why?
|
| Female | 46 | 2021 | 68775 | 0.450 |
Why?
|
| Short Bowel Syndrome | 1 | 2015 | 63 | 0.440 |
Why?
|
| Child | 33 | 2022 | 25302 | 0.440 |
Why?
|
| Infant, Newborn | 17 | 2025 | 8372 | 0.440 |
Why?
|
| Base Sequence | 18 | 2016 | 2760 | 0.440 |
Why?
|
| NF-kappa B | 4 | 2021 | 438 | 0.420 |
Why?
|
| Skin | 2 | 2017 | 517 | 0.420 |
Why?
|
| Biomedical Research | 1 | 2020 | 534 | 0.420 |
Why?
|
| Cross Infection | 5 | 2011 | 334 | 0.410 |
Why?
|
| DNA Transposable Elements | 2 | 2014 | 175 | 0.410 |
Why?
|
| Bottle-Nosed Dolphin | 1 | 2013 | 2 | 0.410 |
Why?
|
| Disease Models, Animal | 12 | 2019 | 4448 | 0.410 |
Why?
|
| Catheter-Related Infections | 2 | 2013 | 137 | 0.400 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2010 | 1008 | 0.390 |
Why?
|
| Lipopolysaccharides | 4 | 2018 | 291 | 0.380 |
Why?
|
| Trachea | 1 | 2014 | 204 | 0.380 |
Why?
|
| DNA | 2 | 2017 | 1422 | 0.370 |
Why?
|
| Escherichia coli | 9 | 2019 | 962 | 0.370 |
Why?
|
| Genes, Bacterial | 7 | 2013 | 216 | 0.370 |
Why?
|
| Mouth | 1 | 2012 | 66 | 0.370 |
Why?
|
| Farnesol | 1 | 2011 | 3 | 0.370 |
Why?
|
| Nutritional Status | 2 | 2020 | 299 | 0.370 |
Why?
|
| RNA Nucleotidyltransferases | 5 | 1997 | 32 | 0.360 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2016 | 296 | 0.360 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 114 | 0.360 |
Why?
|
| Case-Control Studies | 6 | 2019 | 3332 | 0.360 |
Why?
|
| Infant | 15 | 2022 | 12811 | 0.360 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2017 | 71 | 0.360 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2013 | 149 | 0.350 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 136 | 0.350 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2014 | 334 | 0.350 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 158 | 0.350 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 623 | 0.350 |
Why?
|
| Brain | 4 | 2021 | 3053 | 0.340 |
Why?
|
| Intubation, Intratracheal | 1 | 2014 | 285 | 0.340 |
Why?
|
| Organoids | 4 | 2022 | 283 | 0.340 |
Why?
|
| RNA, Ribosomal, 23S | 5 | 2004 | 21 | 0.340 |
Why?
|
| Metabolomics | 4 | 2024 | 455 | 0.340 |
Why?
|
| Staphylococcal Infections | 5 | 2010 | 565 | 0.330 |
Why?
|
| Molecular Sequence Data | 19 | 2011 | 3588 | 0.330 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 2314 | 0.330 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2901 | 0.330 |
Why?
|
| Clarithromycin | 6 | 2001 | 126 | 0.320 |
Why?
|
| Cystic Fibrosis | 1 | 2013 | 262 | 0.320 |
Why?
|
| Mucins | 2 | 2020 | 67 | 0.320 |
Why?
|
| Interleukin-8 | 3 | 2016 | 204 | 0.320 |
Why?
|
| DNA, Fungal | 2 | 2017 | 74 | 0.310 |
Why?
|
| Microbiology | 1 | 2009 | 7 | 0.300 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 223 | 0.300 |
Why?
|
| Flavoproteins | 1 | 2009 | 20 | 0.300 |
Why?
|
| Bacterial Toxins | 3 | 2020 | 171 | 0.300 |
Why?
|
| Cell Movement | 2 | 2012 | 852 | 0.300 |
Why?
|
| Neurotransmitter Agents | 2 | 2021 | 140 | 0.300 |
Why?
|
| Gram-Negative Bacteria | 2 | 2008 | 72 | 0.290 |
Why?
|
| Adolescent | 20 | 2020 | 20158 | 0.290 |
Why?
|
| Child, Preschool | 16 | 2020 | 14467 | 0.290 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2019 | 484 | 0.290 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 107 | 0.290 |
Why?
|
| Human Genome Project | 1 | 2008 | 54 | 0.290 |
Why?
|
| Body Weight | 1 | 2012 | 971 | 0.280 |
Why?
|
| Milk, Human | 3 | 2020 | 308 | 0.280 |
Why?
|
| Catheters, Indwelling | 1 | 2009 | 150 | 0.280 |
Why?
|
| Transcription Factors | 3 | 2018 | 2345 | 0.270 |
Why?
|
| Bacterial Infections | 3 | 2007 | 322 | 0.270 |
Why?
|
| Microbial Sensitivity Tests | 10 | 2010 | 823 | 0.270 |
Why?
|
| Staphylococcus aureus | 4 | 2009 | 475 | 0.270 |
Why?
|
| Cell Line | 9 | 2016 | 2566 | 0.270 |
Why?
|
| Obesity | 4 | 2014 | 2338 | 0.270 |
Why?
|
| Models, Animal | 2 | 2020 | 453 | 0.270 |
Why?
|
| Inflammatory Bowel Diseases | 5 | 2013 | 320 | 0.260 |
Why?
|
| Bioethics | 1 | 2008 | 80 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 186 | 0.260 |
Why?
|
| Catalase | 1 | 2007 | 63 | 0.260 |
Why?
|
| Enterocolitis, Necrotizing | 3 | 2017 | 252 | 0.260 |
Why?
|
| Bacterial Typing Techniques | 7 | 2021 | 101 | 0.260 |
Why?
|
| Candidiasis | 1 | 2008 | 128 | 0.260 |
Why?
|
| Adult | 23 | 2019 | 30611 | 0.260 |
Why?
|
| Pasteurella Infections | 1 | 2006 | 7 | 0.260 |
Why?
|
| Pasteurella multocida | 1 | 2006 | 7 | 0.260 |
Why?
|
| Medical Laboratory Science | 1 | 2006 | 12 | 0.260 |
Why?
|
| Biological Transport | 2 | 2019 | 327 | 0.250 |
Why?
|
| Neonatal Sepsis | 2 | 2025 | 40 | 0.250 |
Why?
|
| DNA Fingerprinting | 9 | 2000 | 104 | 0.250 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2024 | 276 | 0.240 |
Why?
|
| Iron | 1 | 2009 | 300 | 0.240 |
Why?
|
| Diffusion of Innovation | 1 | 2006 | 83 | 0.240 |
Why?
|
| Global Health | 1 | 2010 | 609 | 0.240 |
Why?
|
| Meningitis, Bacterial | 1 | 2006 | 96 | 0.230 |
Why?
|
| Dextran Sulfate | 3 | 2021 | 47 | 0.230 |
Why?
|
| Hepatocytes | 1 | 2007 | 231 | 0.230 |
Why?
|
| Hospitals, Pediatric | 5 | 2021 | 778 | 0.230 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 363 | 0.230 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 376 | 0.230 |
Why?
|
| Respiratory System | 2 | 2018 | 94 | 0.230 |
Why?
|
| Diet | 4 | 2020 | 1105 | 0.230 |
Why?
|
| Microbial Interactions | 2 | 2017 | 15 | 0.220 |
Why?
|
| Methicillin Resistance | 3 | 2006 | 116 | 0.220 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 873 | 0.220 |
Why?
|
| Mutagenesis, Insertional | 3 | 2016 | 149 | 0.220 |
Why?
|
| Polysaccharides | 2 | 2019 | 140 | 0.220 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 289 | 0.220 |
Why?
|
| Glycerol | 2 | 2017 | 80 | 0.220 |
Why?
|
| Rotavirus | 2 | 2020 | 363 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 1206 | 0.220 |
Why?
|
| Repressor Proteins | 1 | 2009 | 764 | 0.220 |
Why?
|
| HT29 Cells | 2 | 2021 | 42 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 417 | 0.220 |
Why?
|
| Culture Media | 3 | 2021 | 173 | 0.210 |
Why?
|
| DNA, Ribosomal | 7 | 2017 | 53 | 0.210 |
Why?
|
| Cluster Analysis | 4 | 2015 | 410 | 0.210 |
Why?
|
| Ribotyping | 2 | 2014 | 49 | 0.210 |
Why?
|
| Ruminococcus | 2 | 2015 | 11 | 0.210 |
Why?
|
| RNA, Bacterial | 3 | 2019 | 53 | 0.200 |
Why?
|
| Drug Synergism | 3 | 2020 | 232 | 0.200 |
Why?
|
| Immunity, Innate | 3 | 2020 | 395 | 0.200 |
Why?
|
| Computer Systems | 1 | 2003 | 36 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 1388 | 0.200 |
Why?
|
| Liver Diseases | 1 | 2007 | 381 | 0.200 |
Why?
|
| Monosaccharides | 2 | 2020 | 20 | 0.200 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 146 | 0.200 |
Why?
|
| Synbiotics | 1 | 2022 | 5 | 0.200 |
Why?
|
| Risk Factors | 5 | 2014 | 10638 | 0.190 |
Why?
|
| Oligosaccharides | 2 | 2020 | 73 | 0.190 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2022 | 23 | 0.190 |
Why?
|
| Meningitis, Viral | 1 | 2002 | 10 | 0.190 |
Why?
|
| Sensitivity and Specificity | 4 | 2025 | 2081 | 0.190 |
Why?
|
| Conserved Sequence | 3 | 2007 | 279 | 0.190 |
Why?
|
| Premature Birth | 3 | 2019 | 404 | 0.190 |
Why?
|
| Encephalitis, Viral | 1 | 2002 | 21 | 0.190 |
Why?
|
| Interleukin-10 | 4 | 2011 | 181 | 0.190 |
Why?
|
| Pregnancy | 8 | 2019 | 7426 | 0.180 |
Why?
|
| Simplexvirus | 1 | 2002 | 100 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2019 | 425 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 4513 | 0.180 |
Why?
|
| Protein Structure, Secondary | 2 | 2016 | 237 | 0.180 |
Why?
|
| Fermentation | 4 | 2017 | 66 | 0.180 |
Why?
|
| Multigene Family | 2 | 2014 | 289 | 0.180 |
Why?
|
| Antibiosis | 2 | 2014 | 14 | 0.180 |
Why?
|
| Stomach | 4 | 2016 | 267 | 0.180 |
Why?
|
| Gene Expression Profiling | 4 | 2013 | 1774 | 0.180 |
Why?
|
| Acids | 1 | 2021 | 28 | 0.170 |
Why?
|
| Vancomycin | 3 | 2017 | 221 | 0.170 |
Why?
|
| Apoptosis | 1 | 2008 | 1823 | 0.170 |
Why?
|
| Disease Susceptibility | 2 | 2014 | 278 | 0.170 |
Why?
|
| Crohn Disease | 4 | 2016 | 290 | 0.170 |
Why?
|
| Gastric Mucosa | 5 | 2016 | 487 | 0.170 |
Why?
|
| DNA, Viral | 1 | 2002 | 448 | 0.170 |
Why?
|
| Incidence | 3 | 2014 | 3264 | 0.170 |
Why?
|
| Mucus | 1 | 2020 | 37 | 0.170 |
Why?
|
| Adenosine Diphosphate | 1 | 2020 | 52 | 0.170 |
Why?
|
| Enterochromaffin Cells | 1 | 2020 | 11 | 0.170 |
Why?
|
| Computational Biology | 6 | 2017 | 835 | 0.170 |
Why?
|
| Receptors, Serotonin | 1 | 2020 | 36 | 0.170 |
Why?
|
| Species Specificity | 5 | 2017 | 516 | 0.170 |
Why?
|
| Adhesins, Bacterial | 1 | 2020 | 71 | 0.160 |
Why?
|
| Symbiosis | 1 | 2021 | 91 | 0.160 |
Why?
|
| Genotype | 5 | 2013 | 2600 | 0.160 |
Why?
|
| Ethanol | 1 | 2021 | 159 | 0.160 |
Why?
|
| ADP Ribose Transferases | 1 | 2020 | 20 | 0.160 |
Why?
|
| Time Factors | 4 | 2020 | 6172 | 0.160 |
Why?
|
| Betacoronavirus | 2 | 2020 | 285 | 0.160 |
Why?
|
| Acetates | 1 | 2020 | 81 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 137 | 0.160 |
Why?
|
| Actin Cytoskeleton | 1 | 2020 | 48 | 0.160 |
Why?
|
| Cell Shape | 1 | 2020 | 70 | 0.160 |
Why?
|
| Vero Cells | 1 | 2020 | 112 | 0.160 |
Why?
|
| Enterotoxins | 1 | 2020 | 77 | 0.160 |
Why?
|
| Serine Endopeptidases | 2 | 2017 | 191 | 0.160 |
Why?
|
| DNA Barcoding, Taxonomic | 2 | 2019 | 18 | 0.160 |
Why?
|
| DNA Replication | 3 | 1997 | 346 | 0.150 |
Why?
|
| Pandemics | 3 | 2021 | 1141 | 0.150 |
Why?
|
| Microspheres | 1 | 2019 | 68 | 0.150 |
Why?
|
| Virulence | 1 | 2020 | 270 | 0.150 |
Why?
|
| Secretory Pathway | 1 | 2019 | 10 | 0.150 |
Why?
|
| Molecular Epidemiology | 4 | 2013 | 145 | 0.150 |
Why?
|
| Rats | 3 | 2016 | 3397 | 0.150 |
Why?
|
| Enteroendocrine Cells | 1 | 2019 | 18 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 271 | 0.150 |
Why?
|
| Gastrointestinal Hormones | 1 | 2019 | 20 | 0.150 |
Why?
|
| Preoperative Care | 1 | 2021 | 355 | 0.150 |
Why?
|
| RNA, Messenger | 4 | 2018 | 2542 | 0.150 |
Why?
|
| Point Mutation | 2 | 1997 | 335 | 0.150 |
Why?
|
| HIV-1 | 1 | 2002 | 469 | 0.150 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 361 | 0.150 |
Why?
|
| Ethionine | 1 | 2018 | 1 | 0.150 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 58 | 0.150 |
Why?
|
| Histamine H1 Antagonists | 1 | 2018 | 13 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 227 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2020 | 226 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 373 | 0.150 |
Why?
|
| Amino Acid Sequence | 5 | 2011 | 2543 | 0.150 |
Why?
|
| Membrane Potentials | 1 | 2019 | 294 | 0.150 |
Why?
|
| Homeostasis | 2 | 2021 | 692 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 2 | 2019 | 308 | 0.140 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 148 | 0.140 |
Why?
|
| Dietary Fiber | 2 | 2016 | 78 | 0.140 |
Why?
|
| HeLa Cells | 1 | 2020 | 684 | 0.140 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2018 | 8 | 0.140 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 54 | 0.140 |
Why?
|
| Healthy Volunteers | 2 | 2016 | 149 | 0.140 |
Why?
|
| Carbon | 1 | 2018 | 88 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 429 | 0.140 |
Why?
|
| Age Factors | 2 | 2015 | 2815 | 0.140 |
Why?
|
| Motor Skills | 1 | 2018 | 76 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 251 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 422 | 0.140 |
Why?
|
| Bacteriocins | 1 | 2017 | 6 | 0.140 |
Why?
|
| Mutation | 6 | 2017 | 5950 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 493 | 0.140 |
Why?
|
| Chemical Fractionation | 1 | 2017 | 15 | 0.140 |
Why?
|
| Models, Biological | 3 | 2019 | 1374 | 0.140 |
Why?
|
| Serpins | 1 | 2017 | 34 | 0.140 |
Why?
|
| Chromatography, Liquid | 3 | 2024 | 231 | 0.130 |
Why?
|
| Polyamines | 1 | 2017 | 35 | 0.130 |
Why?
|
| Noncommunicable Diseases | 1 | 2017 | 19 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 303 | 0.130 |
Why?
|
| Survival Analysis | 2 | 2019 | 1501 | 0.130 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2018 | 92 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2022 | 6251 | 0.130 |
Why?
|
| Flow Cytometry | 1 | 2019 | 755 | 0.130 |
Why?
|
| Zika Virus | 1 | 2019 | 152 | 0.130 |
Why?
|
| Vitamins | 1 | 2017 | 110 | 0.130 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 110 | 0.130 |
Why?
|
| Streptococcus pneumoniae | 3 | 1995 | 380 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2017 | 142 | 0.130 |
Why?
|
| Myeloid Cells | 1 | 2017 | 106 | 0.130 |
Why?
|
| Operon | 2 | 1994 | 48 | 0.130 |
Why?
|
| Sigma Factor | 2 | 1994 | 36 | 0.130 |
Why?
|
| Glucose | 1 | 2021 | 839 | 0.130 |
Why?
|
| Molecular Typing | 2 | 2014 | 32 | 0.130 |
Why?
|
| Tetrahydrofolates | 1 | 2016 | 16 | 0.130 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 1994 | 75 | 0.130 |
Why?
|
| Spleen | 1 | 2017 | 254 | 0.130 |
Why?
|
| Phenotype | 6 | 2019 | 4309 | 0.120 |
Why?
|
| Folic Acid | 1 | 2018 | 282 | 0.120 |
Why?
|
| Epidemics | 1 | 2017 | 56 | 0.120 |
Why?
|
| Social Behavior | 1 | 2018 | 217 | 0.120 |
Why?
|
| Bacterial Adhesion | 2 | 2020 | 102 | 0.120 |
Why?
|
| Perinatology | 1 | 2016 | 36 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 1127 | 0.120 |
Why?
|
| Psyllium | 1 | 2016 | 13 | 0.120 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1996 | 23 | 0.120 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 58 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2018 | 2400 | 0.120 |
Why?
|
| Serum Amyloid A Protein | 1 | 2015 | 22 | 0.120 |
Why?
|
| In Situ Hybridization | 2 | 2019 | 449 | 0.120 |
Why?
|
| Prebiotics | 2 | 2012 | 26 | 0.120 |
Why?
|
| Thinness | 2 | 2014 | 69 | 0.120 |
Why?
|
| Texas | 6 | 2020 | 3565 | 0.120 |
Why?
|
| Calcium | 1 | 2020 | 1031 | 0.120 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2312 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 979 | 0.120 |
Why?
|
| Community-Acquired Infections | 3 | 2009 | 249 | 0.120 |
Why?
|
| Treatment Outcome | 8 | 2022 | 12583 | 0.120 |
Why?
|
| DNA Primers | 4 | 2012 | 604 | 0.120 |
Why?
|
| Immunohistochemistry | 3 | 2019 | 1601 | 0.120 |
Why?
|
| Young Adult | 9 | 2020 | 9707 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 24 | 0.120 |
Why?
|
| Immunity | 2 | 2013 | 175 | 0.110 |
Why?
|
| Gammaproteobacteria | 1 | 2015 | 21 | 0.110 |
Why?
|
| Bacillus | 1 | 2015 | 36 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 150 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2017 | 351 | 0.110 |
Why?
|
| Histones | 1 | 2018 | 503 | 0.110 |
Why?
|
| Viruses | 1 | 2016 | 114 | 0.110 |
Why?
|
| Memory | 1 | 2018 | 348 | 0.110 |
Why?
|
| Transcriptome | 2 | 2012 | 1072 | 0.110 |
Why?
|
| Klebsiella | 1 | 2014 | 10 | 0.110 |
Why?
|
| Escherichia coli Proteins | 1 | 1997 | 297 | 0.110 |
Why?
|
| Classification | 1 | 2014 | 18 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 1133 | 0.110 |
Why?
|
| Double-Blind Method | 5 | 2022 | 1602 | 0.110 |
Why?
|
| Staphylococcus | 1 | 2014 | 68 | 0.110 |
Why?
|
| DNA Probes | 4 | 2011 | 120 | 0.110 |
Why?
|
| Culture Media, Conditioned | 3 | 2016 | 82 | 0.110 |
Why?
|
| Glucosyltransferases | 1 | 2014 | 39 | 0.110 |
Why?
|
| Chorioamnionitis | 1 | 2014 | 44 | 0.110 |
Why?
|
| Gene Order | 1 | 2014 | 78 | 0.100 |
Why?
|
| Gestational Age | 2 | 2017 | 1199 | 0.100 |
Why?
|
| Drug Resistance, Microbial | 7 | 2001 | 195 | 0.100 |
Why?
|
| Artificial Gene Fusion | 1 | 2013 | 11 | 0.100 |
Why?
|
| Cholesterol | 2 | 2014 | 537 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2015 | 406 | 0.100 |
Why?
|
| Ribosomal Proteins | 2 | 1994 | 71 | 0.100 |
Why?
|
| Chlorides | 1 | 2014 | 98 | 0.100 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 118 | 0.100 |
Why?
|
| Breath Tests | 3 | 2016 | 182 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2017 | 1538 | 0.100 |
Why?
|
| Micrococcaceae | 1 | 2013 | 4 | 0.100 |
Why?
|
| Protons | 1 | 2014 | 99 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2017 | 382 | 0.100 |
Why?
|
| Actinomycetales Infections | 1 | 2013 | 14 | 0.100 |
Why?
|
| Haemophilus influenzae | 1 | 1993 | 135 | 0.100 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 642 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2014 | 224 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1100 | 0.100 |
Why?
|
| Penicillin Resistance | 1 | 1993 | 81 | 0.100 |
Why?
|
| Population Surveillance | 2 | 2006 | 395 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 561 | 0.100 |
Why?
|
| Cellulose | 1 | 2013 | 28 | 0.100 |
Why?
|
| DNA Primase | 5 | 1997 | 21 | 0.100 |
Why?
|
| Helminthiasis | 1 | 2014 | 82 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2013 | 51 | 0.100 |
Why?
|
| Celiac Disease | 1 | 2013 | 75 | 0.100 |
Why?
|
| Virulence Factors | 1 | 2014 | 170 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 83 | 0.100 |
Why?
|
| Heart Transplantation | 1 | 2019 | 865 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3503 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2013 | 346 | 0.100 |
Why?
|
| Enteric Nervous System | 1 | 2012 | 42 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 1232 | 0.090 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 234 | 0.090 |
Why?
|
| Birth Weight | 1 | 2014 | 342 | 0.090 |
Why?
|
| Haplotypes | 1 | 2014 | 525 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 2754 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 634 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 291 | 0.090 |
Why?
|
| Weight Gain | 1 | 2014 | 377 | 0.090 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 68 | 0.090 |
Why?
|
| Ethics, Research | 1 | 2012 | 54 | 0.090 |
Why?
|
| Nafcillin | 1 | 2011 | 13 | 0.090 |
Why?
|
| Evolution, Molecular | 2 | 2014 | 650 | 0.090 |
Why?
|
| Colony Count, Microbial | 1 | 2011 | 86 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 85 | 0.090 |
Why?
|
| DNA Methylation | 2 | 2016 | 1032 | 0.090 |
Why?
|
| Haemophilus parainfluenzae | 1 | 2011 | 11 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2016 | 1198 | 0.090 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2011 | 44 | 0.090 |
Why?
|
| Helicobacter | 2 | 2002 | 18 | 0.090 |
Why?
|
| Anxiety | 1 | 2018 | 964 | 0.090 |
Why?
|
| Infection Control | 1 | 2013 | 158 | 0.090 |
Why?
|
| Biological Assay | 1 | 2012 | 106 | 0.090 |
Why?
|
| Serologic Tests | 2 | 2020 | 122 | 0.090 |
Why?
|
| Systems Biology | 1 | 2011 | 60 | 0.090 |
Why?
|
| Vitamin B 12 | 1 | 2011 | 57 | 0.090 |
Why?
|
| Infant Formula | 1 | 2012 | 104 | 0.090 |
Why?
|
| Antibodies | 1 | 2012 | 352 | 0.090 |
Why?
|
| Immunoglobulin G | 3 | 2011 | 793 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 333 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 712 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 55 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 276 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2012 | 272 | 0.080 |
Why?
|
| Gastroenterology | 1 | 2013 | 218 | 0.080 |
Why?
|
| HIV Infections | 1 | 2002 | 1954 | 0.080 |
Why?
|
| Monocytes | 2 | 2011 | 330 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 351 | 0.080 |
Why?
|
| Methyltransferases | 1 | 2011 | 78 | 0.080 |
Why?
|
| Acute Disease | 2 | 2010 | 1142 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2014 | 891 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 192 | 0.080 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 1148 | 0.080 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2011 | 161 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2014 | 1659 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1932 | 0.080 |
Why?
|
| Informed Consent | 2 | 2012 | 338 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 316 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 536 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 294 | 0.080 |
Why?
|
| Carrier State | 1 | 2010 | 80 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2011 | 182 | 0.080 |
Why?
|
| Immunoglobulin M | 1 | 1990 | 211 | 0.080 |
Why?
|
| Syphilis | 1 | 1990 | 94 | 0.080 |
Why?
|
| Overweight | 1 | 2012 | 372 | 0.080 |
Why?
|
| Gene Expression | 1 | 2014 | 1487 | 0.080 |
Why?
|
| Molecular Biology | 2 | 2007 | 68 | 0.080 |
Why?
|
| Chromosomes, Bacterial | 3 | 1997 | 65 | 0.070 |
Why?
|
| Bacteroidetes | 2 | 2022 | 23 | 0.070 |
Why?
|
| Norfloxacin | 1 | 2008 | 5 | 0.070 |
Why?
|
| Social Change | 1 | 2008 | 15 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 754 | 0.070 |
Why?
|
| Ofloxacin | 1 | 2008 | 30 | 0.070 |
Why?
|
| Medical Records | 2 | 2007 | 180 | 0.070 |
Why?
|
| Urogenital System | 1 | 2008 | 35 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1382 | 0.070 |
Why?
|
| Levofloxacin | 1 | 2008 | 48 | 0.070 |
Why?
|
| Mycological Typing Techniques | 1 | 2008 | 4 | 0.070 |
Why?
|
| Urease | 3 | 2003 | 74 | 0.070 |
Why?
|
| Shigella sonnei | 1 | 2008 | 3 | 0.070 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2008 | 6 | 0.070 |
Why?
|
| Ciprofloxacin | 1 | 2008 | 67 | 0.070 |
Why?
|
| Salmonella enterica | 1 | 2008 | 9 | 0.070 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2008 | 7 | 0.070 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2008 | 33 | 0.070 |
Why?
|
| Antigens, Bacterial | 2 | 2003 | 313 | 0.070 |
Why?
|
| I-kappa B Proteins | 1 | 2008 | 38 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 1 | 2008 | 108 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1601 | 0.070 |
Why?
|
| Chemokine CCL2 | 1 | 2008 | 111 | 0.070 |
Why?
|
| Vibrio cholerae | 1 | 2008 | 29 | 0.070 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 54 | 0.070 |
Why?
|
| Confidentiality | 1 | 2008 | 104 | 0.070 |
Why?
|
| Fluoroquinolones | 1 | 2008 | 93 | 0.070 |
Why?
|
| Leukemia, Myeloid | 1 | 2008 | 79 | 0.070 |
Why?
|
| United States | 6 | 2012 | 11428 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 231 | 0.070 |
Why?
|
| Esterases | 1 | 2007 | 12 | 0.070 |
Why?
|
| Autoantibodies | 1 | 1990 | 423 | 0.070 |
Why?
|
| Periplasm | 1 | 2007 | 8 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3076 | 0.070 |
Why?
|
| Ubiquitin | 1 | 2008 | 130 | 0.070 |
Why?
|
| Pathology, Clinical | 1 | 2007 | 20 | 0.070 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2018 | 28 | 0.070 |
Why?
|
| Cell Wall | 1 | 2007 | 41 | 0.070 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 327 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2008 | 137 | 0.060 |
Why?
|
| Recurrence | 2 | 2022 | 1422 | 0.060 |
Why?
|
| Research | 1 | 2008 | 257 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2005 | 297 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 187 | 0.060 |
Why?
|
| Aging | 1 | 2014 | 1207 | 0.060 |
Why?
|
| Cross Reactions | 1 | 2007 | 181 | 0.060 |
Why?
|
| Education, Continuing | 1 | 2006 | 30 | 0.060 |
Why?
|
| Disease Outbreaks | 2 | 2007 | 308 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2012 | 709 | 0.060 |
Why?
|
| Models, Immunological | 1 | 2006 | 37 | 0.060 |
Why?
|
| Genetic Variation | 1 | 1993 | 1509 | 0.060 |
Why?
|
| Proteobacteria | 2 | 2017 | 16 | 0.060 |
Why?
|
| Hygiene | 1 | 2006 | 23 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 251 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 1200 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2007 | 172 | 0.060 |
Why?
|
| Hypersensitivity | 1 | 2008 | 225 | 0.060 |
Why?
|
| Burkholderia gladioli | 1 | 2005 | 2 | 0.060 |
Why?
|
| Bile Acids and Salts | 1 | 2008 | 243 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2006 | 1712 | 0.060 |
Why?
|
| Burkholderia Infections | 1 | 2005 | 8 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2007 | 802 | 0.060 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2005 | 70 | 0.060 |
Why?
|
| Ischemia | 1 | 2008 | 343 | 0.060 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 251 | 0.060 |
Why?
|
| Microcephaly | 2 | 2019 | 344 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 1168 | 0.060 |
Why?
|
| Liver | 2 | 2014 | 1765 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 421 | 0.050 |
Why?
|
| Citrobacter | 2 | 1995 | 21 | 0.050 |
Why?
|
| Listeria monocytogenes | 2 | 1994 | 30 | 0.050 |
Why?
|
| Bias | 1 | 2025 | 137 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1996 | 252 | 0.050 |
Why?
|
| Caliciviridae Infections | 1 | 2007 | 279 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1996 | 40 | 0.050 |
Why?
|
| Catheterization, Central Venous | 1 | 2005 | 140 | 0.050 |
Why?
|
| Norovirus | 1 | 2007 | 279 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2007 | 1058 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1295 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2014 | 17083 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2003 | 64 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 524 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3720 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 2005 | 208 | 0.050 |
Why?
|
| Lactates | 1 | 2022 | 78 | 0.050 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2022 | 33 | 0.050 |
Why?
|
| Drug Resistance, Viral | 1 | 2002 | 54 | 0.050 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2003 | 59 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 218 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2022 | 144 | 0.050 |
Why?
|
| Peptic Ulcer | 1 | 2003 | 147 | 0.050 |
Why?
|
| Mentha piperita | 1 | 2022 | 12 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 150 | 0.050 |
Why?
|
| Plant Oils | 1 | 2022 | 32 | 0.050 |
Why?
|
| Bifidobacteriales Infections | 1 | 2021 | 5 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2002 | 240 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2021 | 62 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2002 | 66 | 0.040 |
Why?
|
| Constipation | 1 | 2022 | 122 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 247 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2002 | 99 | 0.040 |
Why?
|
| Calibration | 1 | 2021 | 95 | 0.040 |
Why?
|
| Tyrosine | 1 | 2021 | 146 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 252 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2001 | 138 | 0.040 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2020 | 9 | 0.040 |
Why?
|
| Fructans | 1 | 2020 | 12 | 0.040 |
Why?
|
| Nitroreductases | 1 | 2000 | 7 | 0.040 |
Why?
|
| Flagella | 1 | 2020 | 27 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2011 | 586 | 0.040 |
Why?
|
| Viral Load | 1 | 2002 | 398 | 0.040 |
Why?
|
| Spores, Bacterial | 1 | 2020 | 23 | 0.040 |
Why?
|
| Stomach Diseases | 1 | 2001 | 52 | 0.040 |
Why?
|
| Lactose | 1 | 2020 | 53 | 0.040 |
Why?
|
| Mesocricetus | 1 | 2000 | 69 | 0.040 |
Why?
|
| Bioreactors | 1 | 2020 | 43 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2002 | 511 | 0.040 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2020 | 47 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2020 | 68 | 0.040 |
Why?
|
| Digestive System | 1 | 2000 | 61 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 131 | 0.040 |
Why?
|
| Metronidazole | 1 | 2000 | 157 | 0.040 |
Why?
|
| Genome, Human | 1 | 2006 | 1282 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 320 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2000 | 190 | 0.040 |
Why?
|
| Aged | 6 | 2014 | 20519 | 0.040 |
Why?
|
| Term Birth | 1 | 2019 | 33 | 0.040 |
Why?
|
| Lactation | 1 | 2020 | 195 | 0.040 |
Why?
|
| Cecum | 2 | 2014 | 26 | 0.040 |
Why?
|
| Middle Aged | 7 | 2014 | 27894 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2018 | 21 | 0.040 |
Why?
|
| Genome | 1 | 2021 | 465 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 109 | 0.040 |
Why?
|
| Methionine | 1 | 2018 | 90 | 0.040 |
Why?
|
| Methylation | 1 | 2018 | 196 | 0.040 |
Why?
|
| Duodenal Ulcer | 2 | 1997 | 126 | 0.040 |
Why?
|
| Homocysteine | 1 | 2018 | 118 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 771 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 5161 | 0.030 |
Why?
|
| Enterobacteriaceae Infections | 2 | 1995 | 58 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 787 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2013 | 440 | 0.030 |
Why?
|
| Quality Control | 1 | 2017 | 116 | 0.030 |
Why?
|
| Endopeptidase K | 1 | 2016 | 3 | 0.030 |
Why?
|
| alpha-Amylases | 1 | 2016 | 10 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2003 | 565 | 0.030 |
Why?
|
| Trypsin | 1 | 2016 | 81 | 0.030 |
Why?
|
| Muramidase | 1 | 2016 | 89 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2016 | 27 | 0.030 |
Why?
|
| Health Personnel | 1 | 2021 | 535 | 0.030 |
Why?
|
| Disease Progression | 1 | 2002 | 2125 | 0.030 |
Why?
|
| Lipase | 1 | 2016 | 86 | 0.030 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1994 | 622 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2017 | 173 | 0.030 |
Why?
|
| Consensus Sequence | 2 | 1995 | 51 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2020 | 757 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1137 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 972 | 0.030 |
Why?
|
| Placebos | 1 | 2016 | 226 | 0.030 |
Why?
|
| Disaccharides | 1 | 2015 | 19 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 686 | 0.030 |
Why?
|
| Chloroflexi | 1 | 2014 | 1 | 0.030 |
Why?
|
| Verrucomicrobia | 1 | 2014 | 15 | 0.030 |
Why?
|
| Mycobacterium avium | 1 | 1995 | 16 | 0.030 |
Why?
|
| Actinobacteria | 1 | 2014 | 11 | 0.030 |
Why?
|
| Cyanobacteria | 1 | 2014 | 10 | 0.030 |
Why?
|
| Fluorescence | 1 | 1995 | 97 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 332 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2017 | 243 | 0.030 |
Why?
|
| Mice, Inbred A | 1 | 2014 | 12 | 0.030 |
Why?
|
| Polymers | 1 | 2015 | 109 | 0.030 |
Why?
|
| Gastrins | 1 | 2014 | 30 | 0.030 |
Why?
|
| Klebsiella Infections | 1 | 1995 | 61 | 0.030 |
Why?
|
| Software | 2 | 2012 | 712 | 0.030 |
Why?
|
| Methane | 1 | 2014 | 18 | 0.030 |
Why?
|
| Hydrogen | 1 | 2014 | 42 | 0.030 |
Why?
|
| Streptococcus agalactiae | 1 | 2014 | 102 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 1995 | 83 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 49 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 225 | 0.030 |
Why?
|
| Terminator Regions, Genetic | 1 | 1993 | 8 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 238 | 0.030 |
Why?
|
| Gram-Positive Bacteria | 1 | 1993 | 46 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 996 | 0.020 |
Why?
|
| Serotyping | 1 | 1993 | 172 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1439 | 0.020 |
Why?
|
| Microbial Consortia | 1 | 2012 | 6 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1993 | 169 | 0.020 |
Why?
|
| Behavior | 1 | 2012 | 69 | 0.020 |
Why?
|
| Gastrointestinal Agents | 1 | 2012 | 61 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 2012 | 60 | 0.020 |
Why?
|
| Alleles | 1 | 1997 | 1610 | 0.020 |
Why?
|
| Gastritis | 1 | 1995 | 371 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 132 | 0.020 |
Why?
|
| Research Subjects | 1 | 2012 | 51 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 121 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1991 | 24 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 1991 | 55 | 0.020 |
Why?
|
| Enterobacteriaceae | 1 | 1991 | 40 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 173 | 0.020 |
Why?
|
| Propylene Glycols | 1 | 2011 | 19 | 0.020 |
Why?
|
| Hospitalization | 1 | 2020 | 1880 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 156 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 769 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 6718 | 0.020 |
Why?
|
| Research Personnel | 1 | 2012 | 124 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 131 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 1020 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 425 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 1990 | 63 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1990 | 35 | 0.020 |
Why?
|
| Cardiolipins | 1 | 1990 | 19 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2011 | 205 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 99 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2012 | 189 | 0.020 |
Why?
|
| Fibronectins | 1 | 1990 | 99 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2010 | 92 | 0.020 |
Why?
|
| Leukocidins | 1 | 2010 | 38 | 0.020 |
Why?
|
| Exotoxins | 1 | 2010 | 45 | 0.020 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2010 | 38 | 0.020 |
Why?
|
| Emotions | 1 | 2012 | 356 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 342 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 174 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1406 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2007 | 784 | 0.020 |
Why?
|
| Binding Sites | 1 | 1991 | 1187 | 0.020 |
Why?
|
| Galactosyltransferases | 1 | 1988 | 7 | 0.020 |
Why?
|
| Soft Tissue Infections | 1 | 2010 | 88 | 0.020 |
Why?
|
| Laminin | 1 | 1988 | 67 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 516 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 2111 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1988 | 118 | 0.020 |
Why?
|
| Biopsy | 2 | 2002 | 1237 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2008 | 42 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1988 | 299 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2011 | 345 | 0.020 |
Why?
|
| Rescue Work | 1 | 2007 | 11 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3721 | 0.020 |
Why?
|
| Relief Work | 1 | 2007 | 31 | 0.020 |
Why?
|
| Methicillin | 1 | 2006 | 43 | 0.020 |
Why?
|
| Oligonucleotide Probes | 2 | 1997 | 86 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 3253 | 0.010 |
Why?
|
| Disasters | 1 | 2007 | 100 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 133 | 0.010 |
Why?
|
| Silicones | 1 | 2005 | 32 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 444 | 0.010 |
Why?
|
| Minocycline | 1 | 2005 | 42 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2006 | 154 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 2005 | 20 | 0.010 |
Why?
|
| Meningococcal Infections | 1 | 2005 | 20 | 0.010 |
Why?
|
| Automation | 1 | 2005 | 65 | 0.010 |
Why?
|
| Rifampin | 1 | 2005 | 118 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 380 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 423 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2005 | 2893 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 4804 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 90 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 169 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 1207 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2007 | 766 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 241 | 0.010 |
Why?
|
| Phosphoglucomutase | 1 | 2002 | 7 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2001 | 5 | 0.010 |
Why?
|
| Toxicology | 1 | 2001 | 8 | 0.010 |
Why?
|
| Expert Testimony | 1 | 2001 | 35 | 0.010 |
Why?
|
| Reimbursement Mechanisms | 1 | 2001 | 36 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 2000 | 26 | 0.010 |
Why?
|
| Housing, Animal | 1 | 2000 | 16 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 2001 | 105 | 0.010 |
Why?
|
| Cricetinae | 1 | 2000 | 365 | 0.010 |
Why?
|
| North America | 1 | 2000 | 250 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2001 | 288 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2001 | 270 | 0.010 |
Why?
|
| Chromosome Mapping | 2 | 1992 | 1054 | 0.010 |
Why?
|
| Anemia | 1 | 2001 | 341 | 0.010 |
Why?
|
| rRNA Operon | 1 | 1997 | 3 | 0.010 |
Why?
|
| RNA Probes | 1 | 1997 | 26 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 2999 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1997 | 201 | 0.010 |
Why?
|
| Omeprazole | 1 | 1997 | 100 | 0.010 |
Why?
|
| Anti-Ulcer Agents | 1 | 1997 | 114 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 3597 | 0.010 |
Why?
|
| Herpes Genitalis | 1 | 1995 | 10 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 207 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 1995 | 99 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1995 | 73 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1995 | 94 | 0.010 |
Why?
|
| Bacillus subtilis | 1 | 1994 | 43 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1995 | 148 | 0.010 |
Why?
|
| Diabetes, Gestational | 1 | 1995 | 107 | 0.010 |
Why?
|
| Plasmids | 1 | 1995 | 445 | 0.010 |
Why?
|
| Osmium Tetroxide | 1 | 1991 | 2 | 0.010 |
Why?
|
| Hydroxylamines | 1 | 1991 | 6 | 0.010 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1991 | 17 | 0.010 |
Why?
|
| Temperature | 1 | 1991 | 289 | 0.010 |
Why?
|
| Piperidines | 1 | 1991 | 224 | 0.000 |
Why?
|
| Receptors, Laminin | 1 | 1988 | 3 | 0.000 |
Why?
|
| Lactalbumin | 1 | 1988 | 11 | 0.000 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 1988 | 6 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1988 | 55 | 0.000 |
Why?
|
| Substrate Specificity | 1 | 1988 | 282 | 0.000 |
Why?
|